Fisher & Paykel Healthcare (NZSE:FPH) EBITDA Margin % : 24.97% (As of Sep. 2023)

View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Fisher & Paykel Healthcare's EBITDA for the six months ended in Sep. 2023 was NZ$204 Mil. Fisher & Paykel Healthcare's Revenue for the six months ended in Sep. 2023 was NZ$816 Mil. Therefore, Fisher & Paykel Healthcare's EBITDA margin for the quarter that ended in Sep. 2023 was 24.97%.

Fisher & Paykel Healthcare EBITDA Margin % Historical Data

The historical data trend for Fisher & Paykel Healthcare's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare EBITDA Margin % Chart

Fisher & Paykel Healthcare Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBITDA Margin %

Get a 7-Day Free Trial

31.49

34.19

41.48

36.84

27.30

Fisher & Paykel Healthcare Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBITDA Margin %	Get a 7-Day Free Trial															39.73	33.51	23.90	29.94	24.97

Competitive Comparison of Fisher & Paykel Healthcare's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fisher & Paykel Healthcare's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's EBITDA Margin % falls into.

Fisher & Paykel Healthcare EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Fisher & Paykel Healthcare's EBITDA Margin % for the fiscal year that ended in Mar. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Mar. 2023 )	/	Revenue (A: Mar. 2023 )
	=	433.7	/	1588.6
	=	27.30 %

Fisher & Paykel Healthcare's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	203.7	/	815.8
	=	24.97 %

Fisher & Paykel Healthcare (NZSE:FPH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Fisher & Paykel Healthcare EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

FSPKF:USA FPLB:Germany FPH:Australia

Address

15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013

Website

https://www.fphcare.com

Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.